首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   233505篇
  免费   13665篇
  国内免费   7169篇
耳鼻咽喉   2832篇
儿科学   8308篇
妇产科学   3166篇
基础医学   18993篇
口腔科学   4352篇
临床医学   27236篇
内科学   40612篇
皮肤病学   3156篇
神经病学   14850篇
特种医学   12346篇
外国民族医学   22篇
外科学   33761篇
综合类   20993篇
现状与发展   27篇
预防医学   15190篇
眼科学   4867篇
药学   26683篇
  79篇
中国医学   5438篇
肿瘤学   11428篇
  2023年   2113篇
  2022年   3909篇
  2021年   9469篇
  2020年   5779篇
  2019年   11579篇
  2018年   6183篇
  2017年   5540篇
  2016年   7632篇
  2015年   10375篇
  2014年   18503篇
  2013年   16803篇
  2012年   19604篇
  2011年   16355篇
  2010年   15168篇
  2009年   14725篇
  2008年   13337篇
  2007年   13341篇
  2006年   11265篇
  2005年   7485篇
  2004年   3943篇
  2003年   3410篇
  2002年   2782篇
  2001年   2220篇
  2000年   1931篇
  1999年   1201篇
  1998年   1600篇
  1997年   1447篇
  1996年   1213篇
  1995年   1331篇
  1994年   1266篇
  1993年   991篇
  1992年   1240篇
  1991年   1109篇
  1990年   1153篇
  1989年   1104篇
  1988年   1042篇
  1987年   911篇
  1986年   769篇
  1985年   1743篇
  1984年   1945篇
  1983年   1403篇
  1982年   1504篇
  1981年   1448篇
  1980年   1276篇
  1979年   1014篇
  1978年   789篇
  1977年   786篇
  1976年   683篇
  1974年   458篇
  1973年   440篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
51.
《Drug discovery today》2022,27(1):223-233
Approaches based on animal and two-dimensional (2D) cell culture models cannot ensure reliable results in modeling novel pathogens or in drug testing in the short term; therefore, there is rising interest in platforms such as organoids. To develop a toolbox that can be used successfully to overcome current issues in modeling various infections, it is essential to provide a framework of recent achievements in applying organoids. Organoids have been used to study viruses, bacteria, and protists that cause, for example, respiratory, gastrointestinal, and liver diseases. Their future as models of infection will be associated with improvements in system complexity, including abilities to model tissue structure, a dynamic microenvironment, and coinfection.Teaser.Organoids are a flexible tool for modelling viral, bacterial and protist infections. They can provide fast and reliable information on the biology of pathogens and in drug screening, and thus have become essential in combatting emerging infectious diseases.  相似文献   
52.
Ochratoxin A (OTA) is a mycotoxin that mainly causes nephrotoxicity. The single nephrotoxicity of OTA exposure on glomeruli or renal tubule had been well documented, however, the comparison toxicity between it is still unclear. Here, C57BL/6 mice and two types of nephrocyte were treated with concentration-gradient OTA to explore its differentiation nephrotoxicity. Results showed that OTA induced nephrotoxicity in vivo and in vitro, manifested as the deteriorative kidney function in mice and the cut-down cell viability in nephrocyte. Besides, results of murine kidney pathological section and IC50 of two types nephrocyte indicated that OTA-induced toxicity in renal tubule was higher than its in glomeruli. In addition, OTA exposure induced autophagy signaling differentiation expression. It revealed that autophagy was implicated in OTA-induced differential nephrotoxicity in glomeruli and renal tubule. Altogether, we proved that OTA induces a differentiation nephrotoxicity in glomeruli and renal tubule, and it is related to autophagy differential regulation.  相似文献   
53.
54.
垂体腺瘤(PA)通常引起性腺轴的损害,导致女性患者的生育能力下降。妊娠可使垂体增大,而性腺轴的激素分泌也随之发生相应改变。因此,对患有PA的妊娠妇女的规范化管理显得尤为重要。2021年8月,欧洲内分泌学会(ESE)发布了关于妊娠期功能性和无功能性PA的临床指南,该指南从腺瘤的大小、位置和有无内分泌功能方面,描述了从妊娠前到分娩后诊断、治疗的时机和选择。本文在ESE指南的基础上,对该指南进行了解读,总结了该指南的要点,以期结合中国的临床经验及患者特点,为临床医师管理此类患者提供具有实践意义的指导意见。  相似文献   
55.
56.
57.
IntroductionThe Knowledge of Genome Sequencing (KOGS) questionnaire was recently developed to measure knowledge of genomic sequencing (GS), with preliminary psychometric data supporting its reliability and validity. The aim of this study was to test the reliability and validity of the KOGS in a larger sample, and to confirm its utility in a cancer setting.MethodsThe Genetic Cancer Risk in the Young (RisC) study recruits participants with a personal history of cancer, to investigate heritable cancer causes and future cancer risk using germline GS. Participants (n = 261) in a psychosocial substudy of RisC completed a questionnaire after consent to RisC but before GS, including the KOGS, the Intolerance of Uncertainty Scale, the Chew health literacy scale and items assessing demographic and disease variables. Confirmatory factor analysis (CFA), Cronbach alpha and correlational analyses were undertaken.ResultsThe CFA testing a single-factor model yielded a good model fit, χ2/df = 2.43, comparative fit index (CFI) = 0.97, root mean square error of approximation (RMSEA) = 0.07 and weighted mean root square (WRMR) = 1.03. Factor loadings of all items were above 0.60 and ranged between.66 and.93. The single factor score demonstrated excellent internal consistency (α = 0.82). KOGS scores were significantly associated with health literacy (r = 0.23, p < .001), having a university education [t(258) = ?4.53, p < .001] and having a medical or science background [t(259) = ?3.52, p < .001] but not with speaking a language other than English at home, time since diagnosis, previous genetic counselling/testing or intolerance of uncertainty.DiscussionThis study confirmed a single-factor structure for the KOGS, and its reliability and validity in a cancer population. Associations with measures of health literacy and education were significant and positive as expected, supporting the KOG’s construct validity. Previous genetic counselling may not be sufficient to provide specific knowledge of GS.  相似文献   
58.
59.
《Drug discovery today》2022,27(1):246-256
Bromodomain-containing protein 4 (BRD4) is emerging as a therapeutic target that acts synergistically with other targets of small-molecule drugs in cancer. Therefore, the discovery of potential new dual-target inhibitors of BRD4 may be a promising strategy for cancer therapy. In this review, we highlight a series of strategies to design therapeutic dual-target inhibitors of BRD4 that focus on the synergistic functions of this protein. Drug combinations that exploit synthetic lethality, protein–protein interactions, functional complementarity, and blocking of resistance mechanisms could ultimately overcome the barriers inherent to the development of BRD4 inhibitors as future cancer drugs.  相似文献   
60.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号